Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | co-dergocrine mesilate | 5360696 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | co-dergocrine mesilate | 5360696 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | co-dergocrine mesilate | 5360696 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | co-dergocrine mesilate | 5360696 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | co-dergocrine mesilate | 5360696 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | co-dergocrine mesilate | 5360696 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | mitoxantrone | 4212 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | mitoxantrone | 4212 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | mitoxantrone | 4212 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | mitoxantrone | 4212 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | mitoxantrone | 4212 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | mitoxantrone | 4212 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | mitoxantrone | 4212 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | mitoxantrone | 4212 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | mitoxantrone | 4212 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | mitoxantrone | 4212 | drug-path |
| PPAR signaling pathway | R-HSA-168638 | map03320 | mitoxantrone | 4212 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | mitoxantrone | 4212 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | mitoxantrone | 4212 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | mitoxantrone | 4212 | drug-path |